Trial Profile

A phase III, international, multicenter, randomized and open label study to evaluate the efficacy on LDLc and blood pressure reduction and safety of Trinomia® versus usual care in patients with very high cardiovascular risk without previous cardiovascular event. The VULCANO trial

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 23 Feb 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aspirin/atorvastatin/ramipril (Primary) ; Antihyperlipidaemics; Antiplatelets
Indications Cardiovascular disorders
Focus Registrational; Therapeutic Use
Acronyms VULCANO
Sponsors Ferrer

23 Feb 2021 The trial has been completed in Portugal, according to the European Clinical Trials Database record.
17 Jan 2020 The trial has been completed in Spain, according to the European Clinical Trials Database record.
02 Jul 2019 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com